Skin Reactions to Cancer Immunotherapy
Trial Objectives
A new cancer treatment, called immunotherapy, enhances the body’s immune response to attack and kill cancers. However, by changing the body’s immune response, unwanted side effects can occur. This study focuses on side effects caused by immunotherapy, specifically skin reactions. The purpose of this study is to understand what changes in the immune system, and how these changes lead to skin reactions as a side effect. By understanding these changes, our goal is to define the best treatment for the skin reactions, or possibly prevent the reactions.
Who Can Participate
Adults who have been diagnosed with a solid tumor who are starting or already receiving immunotherapy for cancer treatment.
Age: 18+ Gender: Any
Estimated Time Commitment
Up to 2 visits over 3 months, with possible phone follow-up after 12 months depending on cancer treatment response
Payment & Reimbursement
Payment: Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Daniell Plomondon
303.270.2041
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Principal Investigators
-
Jeffrey Kern, MD
-
Donald Y M Leung, MD, PhD